- Home
- JDZG vs BIAF Comparison
JDZG vs BIAF Comparison
Compare JDZG & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- BIAF
- Stock Information
- Founded
- JDZG 2020
- BIAF 2014
- Country
- JDZG China
- BIAF United States
- Employees
- JDZG N/A
- BIAF N/A
- Industry
- JDZG Other Consumer Services
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- JDZG Real Estate
- BIAF Health Care
- Exchange
- JDZG Nasdaq
- BIAF Nasdaq
- Market Cap
- JDZG 6.2M
- BIAF 6.6M
- IPO Year
- JDZG 2024
- BIAF 2022
- Fundamental
- Price
- JDZG $1.37
- BIAF $1.45
- Analyst Decision
- JDZG
- BIAF Hold
- Analyst Count
- JDZG 0
- BIAF 1
- Target Price
- JDZG N/A
- BIAF N/A
- AVG Volume (30 Days)
- JDZG 22.7K
- BIAF 122.3K
- Earning Date
- JDZG 11-14-2025
- BIAF 11-14-2025
- Dividend Yield
- JDZG N/A
- BIAF N/A
- EPS Growth
- JDZG N/A
- BIAF N/A
- EPS
- JDZG 0.25
- BIAF N/A
- Revenue
- JDZG $2,567,741.00
- BIAF $6,776,739.00
- Revenue This Year
- JDZG N/A
- BIAF N/A
- Revenue Next Year
- JDZG N/A
- BIAF $20.04
- P/E Ratio
- JDZG $5.79
- BIAF N/A
- Revenue Growth
- JDZG 20.36
- BIAF N/A
- 52 Week Low
- JDZG $1.19
- BIAF $1.25
- 52 Week High
- JDZG $14.00
- BIAF $46.53
- Technical
- Relative Strength Index (RSI)
- JDZG 39.90
- BIAF 35.73
- Support Level
- JDZG $1.19
- BIAF $1.39
- Resistance Level
- JDZG $1.40
- BIAF $1.53
- Average True Range (ATR)
- JDZG 0.10
- BIAF 0.17
- MACD
- JDZG -0.03
- BIAF -0.02
- Stochastic Oscillator
- JDZG 34.78
- BIAF 22.00
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.